J H Jacob

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

Harry Bleiberg, Thierry Conroy, B Paillot et al. · European Journal of Cancer · 1997 · 347 citations

Esophageal Cancer, Gastrointestinal Oncology, Medicine +7

Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer

Érick Gamelin, R. Delva, J H Jacob et al. · Journal of Clinical Oncology · 2008 · 330 citations

Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.

Thierry Conroy, Pierre-Luc Etienne, Antoine Adenis et al. · Journal of Clinical Oncology · 1996 · 99 citations

A phase III randomized trial of LV5FU2+CPT-11 vs. LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord02/FFCD9802)

Marc Ychou, Jean‐Luc Raoul, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 2005 · 82 citations

Surgical Oncology, Adjuvant Trial, Pathology +16

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

Pierre Michel, Antoine Adenis, F. Di Fiore et al. · British Journal of Cancer · 2006 · 51 citations · Full text

Weekly Cisplatin, Surgical Oncology, Esophageal Cancer +17